Kelly Financial Services LLC Zoetis Inc. Transaction History

Kelly Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$145.54 - $178.83 $145 - $178	1 Added 4.35%	24 $4,000
Q3 2021 Jul 17, 2024	SELL	$189.29 - $209.69 $137,235 - $152,025	-725 Reduced 96.93%	23 $4.47 Million
Q2 2021 Jul 17, 2024	BUY	$155.9 - $187.99 $115,989 - $139,864	744 Added 18600.0%	748 $4,000
Q4 2020 Jul 17, 2024	SELL	$157.07 - $174.35 $157 - $174	-1 Reduced 20.0%	4 $662,000
Q1 2019 Jul 17, 2024	BUY	$81.56 - $100.67 $407 - $503	5 New	5 $503,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.